Cochlear Limited
COH
Rang in Aktien
#3011
Globally, Cochlear Limited specializes in the development and provision of... Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Aktienkurs
$92.90
Marktkapitalisierung
$6.08B
Veränderung (1 Tag)
-0.33%
Veränderung (1 Jahr)
-49.97%
Land
AU
Handel Cochlear Limited (COH)
Kategorie
Healthcare
EPS für Cochlear Limited (COH)
EPS zum June 2026 TTM: $1.59
Laut den aktuellen Finanzberichten und dem Aktienkurs von Cochlear Limited beträgt das aktuelle EPS des Unternehmens (TTM) $1.59. Am Ende des Jahres 2024 betrug das EPS $3.63 eine Steigerung gegenüber dem EPS von 2023, das $3.04 betrug.
EPS-Verlauf von Cochlear Limited von 2000 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $1.59 | -59.41% |
| 2025 | $3.91 | 7.65% |
| 2024 | $3.63 | 19.29% |
| 2023 | $3.04 | 0.33% |
| 2022 | $3.03 | -17.90% |
| 2021 | $3.70 | -229.72% |
| 2020 | $-2.85 | -184.36% |
| 2019 | $3.38 | 6.57% |
| 2018 | $3.17 | 5.55% |
| 2017 | $3.00 | 21.79% |
| 2016 | $2.47 | 25.10% |
| 2015 | $1.97 | 26.64% |
| 2014 | $1.56 | -26.90% |
| 2013 | $2.13 | 108.34% |
| 2012 | $1.02 | -70.03% |
| 2011 | $3.41 | 45.88% |
| 2010 | $2.34 | 23.46% |
| 2009 | $1.89 | -5.11% |
| 2008 | $2.00 | 28.41% |
| 2007 | $1.55 | 42.34% |
| 2006 | $1.09 | 43.49% |
| 2005 | $0.76 | 61.08% |
| 2004 | $0.47 | -35.97% |
| 2003 | $0.74 | 70.03% |
| 2002 | $0.43 | 42.23% |
| 2001 | $0.31 | 27.35% |
| 2000 | $0.24 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| $3.11 | 95.98% |
US
|
|
| $3.59 | 126.23% |
IE
|
|
| $9.73 | 513.15% |
US
|
|
| $2.48 | 56.28% |
US
|
|
| - | - |
DE
|
